MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-WB-10-0070102
Lucis Pharmaceutical Private Limited
Lucis Pharmaceutical Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹64.98 Lakh
▼ 28% YoY
Net profit · FY 2025
₹12.04 Lakh
Net margin 18.5%
EBITDA · FY 2025
₹23.66 Lakh
EBITDA margin 36.4%
Authorised capital
₹51 Lakh
Registered with MCA
Paid-up capital
₹50.2 Lakh
Issued & subscribed
Open charges
₹18.5 Lakh
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
3
As per MCA filings
About Lucis Pharmaceutical Private Limited
Data last updated:
Lucis Pharmaceutical Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 November 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2004PTC100505. Its GSTIN is 19AABCL0807C1Z0 (West Bengal).
The company has an authorised share capital of ₹51 Lakh and a paid-up capital of ₹50.2 Lakh. It is led by directors including Salik Mukhtar and Mukhtar Alam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal, India – 700001.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.98 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹12.04 Lakh (net margin 18.5%) and EBITDA of ₹23.66 Lakh (EBITDA margin 36.4%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹18.5 Lakh on record.
Lucis Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0070102). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239WB2004PTC100505
Registration Number 100505
Incorporation Date 16 November 2004
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0070102
Recognitions & Rankings of Lucis Pharmaceutical
Contact details
Lucis Pharmaceutical Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKolkata, West Bengal, India – 700001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lucis Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Lucis Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lucis Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lucis Pharmaceutical Private Limited, buy the company report.
Financials of Lucis Pharmaceutical Private Limited
FY 2025 filings availableLucis Pharmaceutical Private Limited reported revenue of ₹64.98 Lakh (down 28% YoY) for FY 2025.
Revenue · FY 2025
₹64.98 Lakh ▼ 28%
Net profit · FY 2025
₹12.04 Lakh margin 18.5%
EBITDA · FY 2025
₹23.66 Lakh margin 36.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 26%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▼ 33%
3 years · compounded
▼ 4%
5 years · compounded
▲ 1%
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 28% fall in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.4% | ||||
| Net Profit Margin | 18.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lucis Pharmaceutical Private Limited, buy the company report.
Board of directors of Lucis Pharmaceutical Private Limited
Lucis Pharmaceutical has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Salik Mukhtar | Director | 10 Dec 2018 | 7 Years 10 Months | Current |
| Mukhtar Alam | Director | 16 Nov 2004 | 21 Years 11 Months | Current |
| Shaheena Mukhtar | Director | 16 Nov 2004 | 21 Years 11 Months | Current |
Auditor
Lucis Pharmaceutical Private Limited is audited by BIJAY KUMAR AGARWAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BIJAY KUMAR AGARWAL & CO | FY 2021 | 323267E |
Shareholding
The shareholding of Lucis Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Lucis Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 May 2023 | 100801042 | Hdfc Bank Limited | ₹12 Lakh | Open | |
| 22 Oct 2014 | 10531308 | Vijaya Bank | ₹6.5 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Lucis Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lucis Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lucis Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCL0807C1Z0 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lucis Pharmaceutical Private Limited, buy the company report.
Recent activity
Lucis Pharmaceutical Private Limited has 3 board changes on record since 2004: 3 appointments. The latest: Salik Mukhtar was appointed as Director on 10 Dec 2018.
AGM
Lucis Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Lucis Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.00 Lakh with Charge ID 100801042 was registered on 22 May 2023.
Appointed
Salik Mukhtar was appointed as Director.
Charges
A charge with Vijaya Bank amounted to Rs. 6.50 Lakh with Charge ID 10531308 was registered on 22 Oct 2014.
Appointed
Mukhtar Alam was appointed as Director.
Appointed
Shaheena Mukhtar was appointed as Director.
Incorporation
16 Nov 2004
Lucis Pharmaceutical Private Limited was registered on 16 Nov 2004 with Roc Kolkata I & aged 21 years 11 months as per MCA records.
Frequently asked questions
Lucis Pharmaceutical is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 November 2004 (22+ years old) and is registered under CIN U24239WB2004PTC100505.
Lucis Pharmaceutical has 3 current directors:
- Salik Mukhtar - Director
- Mukhtar Alam - Director
- Shaheena Mukhtar - Director
The latest financial statements of Lucis Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lucis Pharmaceutical is 19AABCL0807C1Z0, registered in West Bengal.
The CIN (Corporate Identification Number) of Lucis Pharmaceutical is U24239WB2004PTC100505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lucis Pharmaceutical was incorporated on 16 November 2004, making it 22+ years old. It is registered with the Registrar of Companies, Kolkata.
Salik Mukhtar was appointed as Director on 10 Dec 2018. Mukhtar Alam was appointed as Director on 16 Nov 2004. Shaheena Mukhtar was appointed as Director on 16 Nov 2004.
Yes, Lucis Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0070102).
The registered office of Lucis Pharmaceutical is at Kolkata, West Bengal, India – 700001.
Lucis Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.